Glycomic Characterization of Induced Pluripotent Stem Cells Derived from a 
Patient Suffering from Phosphomannomutase 2 Congenital Disorder of 
Glycosylation (PMM2-CDG)

Thiesler, Christina T.; Cajic, Samanta; Hoffmann, Dirk; Thiel, Christian; van Diepen, Laura; Hennig, Rene; Sgodda, Malte; Weißmann, Robert; Reichl, Udo; Steinemann, Doris; Diekmann, Ulf; Huber, Nicolas M. B.; Oberbeck, Astrid; Cantz, Tobias; Kuss, Andreas W.; Körner, Christian; Schambach, Axel; Rapp, Erdmann; Buettner, Falk F. R.

doi:10.1074/mcp.M115.054122

Item

ITEM ACTIONSEXPORT

Add to Basket

Local TagsRelease HistoryDetailsSummary

Released

Journal Article

Glycomic Characterization of Induced Pluripotent Stem Cells Derived from a Patient Suffering from Phosphomannomutase 2 Congenital Disorder of Glycosylation (PMM2-CDG)

MPS-Authors

/persons/resource/persons125822

Cajic, Samanta
Bioprocess Engineering, Max Planck Institute for Dynamics of Complex Technical Systems, Max Planck Society;

/persons/resource/persons86321

Hennig, Rene
Bioprocess Engineering, Max Planck Institute for Dynamics of Complex Technical Systems, Max Planck Society;
glyXera GmbH, 39120 Magdeburg, Germany;

/persons/resource/persons86448

Reichl, Udo
Bioprocess Engineering, Max Planck Institute for Dynamics of Complex Technical Systems, Max Planck Society;
Otto-von-Guericke-Universität Magdeburg, External Organizations;

/persons/resource/persons86442

Rapp, Erdmann
Bioprocess Engineering, Max Planck Institute for Dynamics of Complex Technical Systems, Max Planck Society;
glyXera GmbH, 39120 Magdeburg, Germany;

External Resource

No external resources are shared

Fulltext (restricted access)

There are currently no full texts shared for your IP range.

Fulltext (public)

cajic_2382093.pdf
(Publisher version), 4MB

Supplementary Material (public)

There is no public supplementary material available

Citation

Thiesler, C. T., Cajic, S., Hoffmann, D., Thiel, C., van Diepen, L., Hennig, R., et al. (2016). Glycomic Characterization of Induced Pluripotent Stem Cells Derived from a Patient Suffering from Phosphomannomutase 2 Congenital Disorder of Glycosylation (PMM2-CDG). Molecular and Cellular Proteomics, 15(4), 1435-1452. doi:10.1074/mcp.M115.054122.

Cite as: https://hdl.handle.net/11858/00-001M-0000-002C-3BD1-6

Abstract

There is no abstract available